Sanofi
SNY
$48.66
$0.310.64%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -932.44M | -- | 362.84M | -- | |
| Total Depreciation and Amortization | 2.35B | -- | 1.89B | -- | |
| Total Amortization of Deferred Charges | 130.38M | -- | -- | -- | |
| Total Other Non-Cash Items | 372.51M | -- | 2.18B | -- | |
| Change in Net Operating Assets | 2.09B | -- | -- | -- | |
| Cash from Operations | 4.01B | -- | 3.89B | -- | |
| Capital Expenditure | -2.05B | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | 985.99M | -- | -- | -- | |
| Cash Acquisitions | -10.94B | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 9.52B | -- | 1.90B | -- | |
| Cash from Investing | -2.48B | -- | -415.65M | -- | |
| Total Debt Issued | 5.56B | -- | -- | -- | |
| Total Debt Repaid | -4.06B | -- | -- | -- | |
| Issuance of Common Stock | 177.00M | -- | -- | -- | |
| Repurchase of Common Stock | -5.03B | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -5.56B | -- | -- | -- | |
| Other Financing Activities | 5.55B | -- | 1.77B | -- | |
| Cash from Financing | -2.99B | -- | -4.15B | -- | |
| Foreign Exchange rate Adjustments | 8.15M | -- | 15.83M | -- | |
| Miscellaneous Cash Flow Adjustments | 0.00 | -- | -- | -- | |
| Net Change in Cash | -1.45B | -- | -839.30M | -- | |